Former U.S. FDA Commissioner Andrew von Eschenbach On International Regulatory Collaboration: An Interview With PharmAsia News (Part 1 of 2)
This article was originally published in PharmAsia News
Executive Summary
Former U.S. FDA Commissioner Andrew von Eschenbach spoke publicly during his reign at the agency about the need to transform FDA to respond to a globalized marketplace. In January 2008, the agency announced a new program referred to as FDA Beyond Our Borders to establish permanent offices abroad (PharmAsia News, Jan. 28, 2009). Now expecting to split his time between returning to the M.D Anderson Cancer Center in Houston and acting as a senior advisor at Greenleaf Health, a regulatory consulting firm founded by his former chief of staff Patrick Ronan, von Eschenbach spoke with PharmAsia News about his reflections on his time at FDA and the remaining challenges for the agency.